Morgan Stanley raised the firm’s price target on Keurig Dr Pepper (KDP) to $38 from $36 and keeps an Equal Weight rating on the shares following relatively in-line Q4 EPS with “a solid quality result” in terms of 6.2% organic sales growth. The firm calls the valuation “somewhat compelling,” but sees low coffee visibility and SNAP program risk, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Cautious Outlook for Keurig Dr Pepper Amid U.S. Coffee Segment Challenges and Inflation Pressures
- Cautious Outlook for Keurig Dr Pepper Amidst Growth and Cost Concerns
- Optimistic Buy Rating for Keurig Dr Pepper Amidst Promising Growth Prospects and Strong Fundamentals
- Keurig Dr Pepper Reports Strong 2024 Results and 2025 Outlook
- Keurig Dr Pepper price target raised to $34 from $33 at Goldman Sachs